Speech-Language Pathologists in Port Richey, FL Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Ability Tree Learning Center Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6215 Stone Rd, Port Richey, FL 34668 Phone: 727-605-3060

Wayne K Ekren, J.D., M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9330 Regency Park Blvd, Port Richey, FL 34668 Phone: 727-364-9267

Sarah Jane Sharpe, MS, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6215 Stone Rd, Port Richey, FL 34668 Phone: 727-605-3060    Fax: 727-645-5215

Tmj Tx Clinic Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8649 Regency Park Blvd, Port Richey, FL 34668 Phone: 727-843-4035    Fax: 727-817-0475

Derek Gorgas Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7348 Cay Dr, Port Richey, FL 34668 Phone: 352-428-7988

Dr. Peter Roy Johnson, PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4650 Bay Blvd Apt 1021, Port Richey, FL 34668 Phone: 727-849-5531    Fax: 727-849-5531

Mrs. Ina Marie Chancey, M.S./CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8649 Regency Park Blvd, Port Richey, FL 34668 Phone: 727-843-4035    Fax: 727-817-0475

News Archive

Higher surge of testosterone in competition not tied to winning, shows study

A higher surge of testosterone in competition, the so-called "winner effect," is not actually related to winning, suggests a new study of intercollegiate cross country runners.

No recess rest in health reform ad wars

Major groups are promising that the August recess will be filled with advertising wars trying to manage the message of the health care reform debate, Politico reports.

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.

Prolonged TV viewing associated with higher risk of cardiovascular disease, diabetes and all-cause mortality

In an analysis of data from several studies, watching television for 2-3 hours per day or more was associated with a higher risk of type 2 diabetes, fatal and nonfatal cardiovascular disease and all-cause death, according to a study in the June 15 issue of JAMA.

IBS Treatment Center opens new clinic in Santa Monica, California

The IBS Treatment Center, which specializes in treating irritable bowel syndrome, announced the opening of a new clinic in Santa Monica, California, in late October. Conveniently located next to the UCLA Medical Center, this new branch of the clinic will provide a progressive approach to digestive health as well as easy access to treatment for patients previously without adequate care.

Read more Medical News

› Verified 6 days ago